Episode

Ep203: Sri Kosuri on Small Molecule Correctors of Disease

Podcast
The Long Run with Luke Timmerman
Published
Jun 16, 2026
Duration seconds
4303
Processing state
not_requested
Canonical source
https://soundcloud.com/longrunpodcast/ep203-sri-kosuri-on-small
Audio
https://feeds.soundcloud.com/stream/2340409454-longrunpodcast-ep203-sri-kosuri-on-small.mp3
JSON
/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep203-sri-kosuri-on-small-molecule-correctors-of-disease
Markdown
/podcast/the-long-run-with-luke-timmerman-1124799/ep203-sri-kosuri-on-small-molecule-correctors-of-disease.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep203-sri-kosuri-on-small-molecule-correctors-of-disease/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep203-sri-kosuri-on-small-molecule-correctors-of-disease.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Sri Kosuri, co-founder and CEO of Emeryville, Calif.-based Octant Bio, on small molecules designed to correct protein misfolding and mistrafficking at the root of many diseases.